[Current status and perspective of vasculitis in Japan]

Nihon Jinzo Gakkai Shi. 2014;56(2):65-9.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / classification
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / diagnosis
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / epidemiology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / therapy*
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Asian People
  • Cohort Studies
  • Cyclophosphamide / administration & dosage
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Japan / epidemiology
  • Plasma Exchange
  • Prednisolone / administration & dosage
  • Prospective Studies
  • Randomized Controlled Trials as Topic*
  • Remission Induction
  • Renal Dialysis
  • Retrospective Studies
  • Rituximab
  • Severity of Illness Index

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide
  • Prednisolone